Precision Psychiatry Market

Q: What will be the CAGR of the global precision psychiatry industry during the forecast period?

The CAGR is anticipated to be 14.2 % from 2025 to 2035 Read More

Precision Psychiatry Market (Service Type: Genetic Testing, Biomarker Analysis, Data Analytics & Interpretation Services; End-user: Hospitals & Clinics, Clinical Laboratories, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Precision Psychiatry Market Outlook

The global precision psychiatry market size was valued at US$ 0.9 Bn in 2024 and is projected to reach US$ 4.2 Bn by 2035, expanding at a CAGR of 14.2% from 2025 to 2035. The foremost factors leading to the growth of the precision psychiatry industry are the rapid integration of Al and ML tools in psychiatric diagnostics and treatment planning and the extensive adoption of genomics, neuroimaging, and digital phenotyping for identifying biological and behavioral markers of mental health disorders.

Precision Psychiatry Market Size & Highlights

The precision psychiatry market reached US$ 0.9 Bn in 2024.
The market is estimated to reach US$ 4.2 Bn by 2035
The industry is anticipated to expand at a CAGR of 14.2% from 2025 to 2035.
Top companies in the market include Labcorp, Myriad Genetics, Inc., TruGenomix, Inc., GeneDx, LLC, Genomind, CNSDose.
North America dominated the market in 2024, holding the largest revenue share of 38.8% in 2024
By service type, the genetic testing segment held the major market share of 42.5% in 2024

Precision Psychiatry Market By Revenue

Analysts’ Viewpoint regarding Global Precision Psychiatry Market

The global precision psychiatry market is set to grow significantly over the next few years. This growth is likely to be largely influenced by the combination of advanced technologies and the rising consciousness of personalized mental healthcare. The use of genomics, neuroinformatics, and digital health instruments is leading to a more detailed understanding of the biological factors that underlie psychiatric disorders, thus providing less resistance to the arrival of targeted and effective treatment methods.

Additionally, the increased investments in the private and public sectors on equal grounds, as well as the collaborations amongst research institutions, pharmaceutical companies, and technology providers, are accelerating the innovations in this area at rapid pace. Moreover, issues such as high costs for implementation, data privacy concerns, and limited standardization in diagnostic frameworks could slow down the quick adoption of this technology.

With the integration of advanced analytics and real world evidence, predictive models for mental health outcomes are expected to turn out to be more refined as the field continues to evolve. Eventually, precision psychiatry will probably be one of the main elements of future healthcare, connecting the different areas of neuroscience, technology, and personalized patient care.

Precision Psychiatry Market Introduction

The precision psychiatry market represents an emerging segment of the healthcare system that concentrates on the use of personalized medicine concepts for the diagnosis, treatment, and management of mental health disorders. Precision psychiatry, as opposed to standard psychiatry, which typically uses generalized treatment approaches, utilizes character genomic data, neuroimaging, biomarkers, and digital health technologies to adjust the intervention of a patient to his/her unique biological, psychological, and environmental profile.

Such a method seeks to elevate the effectiveness of treatments, lessen the experiments with different drugs in choosing the right medication, and eventually, make the results better for the patients. The increasing rate of mental health disorders globally, along with the innovations in artificial intelligence, big data analytics, and biomarker discovery, are the major factors behind the rise of precision psychiatry products and their subsequent implementation. With the advancements in research and technology being used, the market is anticipated to be the main driver of the change of the global mental healthcare sector.

The innovations and clinical translations in the field are rapid due to the increasing collaborations of biotechnologies firms, academic institutions, and healthcare providers. With the increased awareness and favorable government initiatives, the precision psychiatry market is projected to experience a significant expansion over the next few years.

For instance, the U.S. Food and Drug Administration (FDA) is planning to hold an expert panel review regarding Al-powered devices for mental health. The review will examine safety, effectiveness, and ethical issues of using algorithms for diagnosis and therapy in depression, anxiety, and post-traumatic stress disorder (PTSD). The move is the first significant regulatory attempt to assess Al-based psychiatric tools that are widely anticipated to be the main instruments of precision psychiatry in the clinic.

Attribute	Detail
Market Drivers	Rising Prevalence of Mental Health Disorders Supportive Government Initiatives and Healthcare Infrastructure

Rising Prevalence of Mental Health Disorders Propelling Precision Psychiatry Market

The rising rates of mental health disorders such as depression, anxiety, schizophrenia, and bipolar disorder are among the primary reasons behind the demand for new and personalized treatment approaches. By combining genetic, biological, and behavioral data to figure out the most effective interventions for each patient's unique profile, precision psychiatry provides a hopeful prospect as a far-reaching alternative. Apart from improving treatment and patient results, the initiative to personalized care is also intended to reduce the social and economic costs that are a global consequence of mental health disorders.

As per the World Health Organization, more than 1 billion people are living with mental health disorders with anxiety and depression inflicting immense human and economic tolls. Despite global efforts, progress in reduction of suicide mortality is too low to meet the United Nations Sustainable Development Goal (SDG) of a one-third reduction in suicide rates by 2030.

Supportive Government Initiatives and Healthcare Infrastructure Accelerating Precision Psychiatry Market

The adoption of precision psychiatry is being heavily influenced by such factors as the governmental support initiatives and the upgrading of medical care facilities. For instance, in regions such as North America and Europe, decision-makers are becoming more aware of the potential that individualized mental health care holds and are therefore implementing the framework in system that will facilitate as a daily routine in clinical practice possible.

The government sector is heavily investing in research programs, data-sharing networks, and digital health platforms. All these enable the implementation of genomics, neuroimaging, and artificial intelligence in the assessment and treatment of psychiatry. Moreover, reimbursement policies, which are supportive, as well as regulatory frameworks, are aligned to facilitate the launching and the initiating into operation of the precision-based mental health solutions to take place at a faster rate.

For instance, as per the National Institute of Mental Health (NIMH) budget request, the agency is planning to allocate a substantial investment from the funds of the Fiscal Year 2024 to its "Precision Psychiatry Initiative", which is a program mainly aimed at the development of biomarkers and the creation of precision diagnostics for major depression. The Framework describes NIMH’s plans for potential funding opportunities, as well as plans for outreach to stakeholders, including people with mental illnesses and their families, patient advocates and advocacy groups, healthcare providers, researchers, and state, local, and federal government partners.

Segment Outlook of Precision Psychiatry Market

Precision Psychiatry Market By Type

Among the different service type, genetic testing is, to a large extent, the main driver of growth for the precision psychiatry market with market share of 42.5%. The growth of this segment is mainly due to the increased application of pharmacogenomics testing that aims at helping medication selection and dosage adjustment for mental health disorders such as depression, anxiety, and schizophrenia.

Genetic testing allows healthcare providers to pin down the differences in a patient's genes that affect how the patient metabolizes a drug and how the patient responds to the treatment thereby psychiatry is still less used in a traditional way of trial and error. It is also important to note that progress in next-generation sequencing (NGS) technologies, lower prices for genetic assays, and more accessible tests from such companies as GeneSight, Myriad Genetics, and Genomind are all contributing to faster adoption of the market.

For instance, The International Society of Psychiatric Genetics (ISPG) has published expanded worldwide standards that describe the ideal usage of genetic testing in mental health. These standards include essential areas like diagnostic genetic panels, pharmacogenetic testing, and moral safeguards for patient data. However, the use of such tests in psychiatric conditions in the general population of adults, for instance, depression bipolar disorder and schizophrenia

Regional Outlook of Precision Psychiatry Market

Precision Psychiatry Market By Region

Attribute	Detail
Leading Region	North America

North America dominates the global precision psychiatry market with 38.8% market share. Currently, the precision psychiatry industry globally is influenced by North America, which holds the highest share in terms of both - revenue and technological progress. The region's dominance is a result of several factors such as heavy backing by the government, an advanced healthcare system, and a substantial investment being focused into mental health research and innovations. Moreover, collaborations amongst universities, research institutions, and tech suppliers are rapidly moving precision psychiatry research into real-world applications. In case of sustained funding and favorable policies, the region of North America will be able to keep its top spot and at the same time create standards worldwide for the innovation and the deployment of the personalized mental health care.

For instance, in June 2025, Brain Canada announced the Canadian federal government, through Health Canada and the Canada Brain Research Fund, investment of US$ 36.8 Mn (with CA$ 18 Mn of the amount to be used for direct grants) in advanced neuroimaging and multi-modal brain-research platforms for psychiatry.

Analysis of Key Players in Precision Psychiatry Market

Labcorp, Myriad Genetics, Inc., TruGenomix, Inc., GeneDx, LLC, Genomind, CNSDose, MedGenome, GeneHealth Global Research & Diagnostics, Quest Diagnostics Incorporated, Illumina, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., QIAGEN, Thermo Fisher Scientific Inc., Fulgent Genetics and others are some of the leading manufacturers operating in the global precision psychiatry market.

Each of these companies has been profiled in the precision psychiatry industry report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.

Key Developments in Precision Psychiatry Market

In July 2025, Polaris Genomics, a U.S.-based company, secured a second USD 100K Maryland Industrial Partnership grant to advance the validation of its PTSD genomic test, accelerating the commercialization of precision psychiatry diagnostics.
In June 2025, U.S.-based GeneDx published the SeqFirst study results in The Journal of Pediatrics. The results showed that rapid genomic testing reduced pediatric diagnostic times from 289 days to 13, supporting broader adoption.
In May 2025, GrayMatters Health (GMH) announced the launch of Prism™ Suite, a next generation, comprehensive portfolio of solutions designed to empower providers and improve patient outcomes. The latest innovation within the portfolio is a Depression protocol that guides patients to learn to regulate brain activity associated with their depression using a reward-system biomarker.
In October 2024, Psyomics Ltd, a UK-based company, revealed that it had entered into a significant collaboration with the Priory Group, a top mental health and social care provider in the UK, to roll out their Al-driven digital triage and assessment platform, Censeo, at various clinical locations.

Precision Psychiatry Market Snapshot

Attribute	Detail
Size in 2024	US$ 0.9 Bn
Forecast Value in 2035	More than US$ 4.2 Bn
CAGR	14.2 %
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	By Service Type Genetic Testing Biomarker Analysis Data Analytics & Interpretation Services Others By Technology Next-Generation Sequencing (NGS) Immunoassay Mass Spectrometry Others By Therapeutic Area Depression and Anxiety Disorders Schizophrenia and Psychotic Disorders Bipolar Disorder Substance Use Disorders Others By End-user Hospitals & Clinics Clinical Laboratories Others
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China India Japan South Korea Australia ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	Labcorp Myriad Genetics, Inc. TruGenomix, Inc GeneDx, LLC Genomind CNSDose MedGenome GeneHealth Global Research & Diagnostics Quest Diagnostics Incorporated Illumina, Inc. F. Hoffmann-La Roche Ltd Bio-Rad Laboratories, Inc. QIAGEN Thermo Fisher Scientific Inc. Fulgent Genetics Other Prominent Players
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global precision psychiatry market in 2024?

The global precision psychiatry market was valued at US$ 0.9 Bn in 2024

How big will the global precision psychiatry industry be in 2035?

The global precision psychiatry industry is projected to reach more than US$ 4.2 Bn by the end of 2035

What are the factors driving the precision psychiatry market?

Rising prevalence of mental health disorders and supportive government initiatives and healthcare infrastructure are some of the factors driving the expansion of precision psychiatry market.

What will be the CAGR of the global precision psychiatry industry during the forecast period?

The CAGR is anticipated to be 14.2 % from 2025 to 2035

Which region will account for a major share of the precision psychiatry sector during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

Who are the prominent players in the global precision psychiatry market?

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global Precision Psychiatry Market
Market Overview
- Introduction
  - Segment Definition
  - Industry Evolution / Developments
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global Precision Psychiatry Market Analysis and Forecast, 2020-2035
  - Market Revenue Projections (US$ Bn)
Key Insights
- Technological Advancement
- Regulatory Scenario by Country/Region
- Distributors Landscape
- PESTEL Analysis
- Market Trends
- Pipeline Analysis
- Porter’s Five Forces Analysis
- Impact Analysis
- Pricing Analysis
Global Precision Psychiatry Market Analysis and Forecast, by Service Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Service Type, 2020-2035
  - Genetic Testing
  - Biomarker Analysis
  - Data Analytics & Interpretation Services
  - Others
- Market Attractiveness Analysis, by Service Type
Global Precision Psychiatry Market Analysis and Forecast, by Technology
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Technology, 2020-2035
  - Next-Generation Sequencing (NGS)
  - Immunoassay
  - Mass Spectrometry
  - Others
- Market Attractiveness Analysis, by Technology
Global Precision Psychiatry Market Analysis and Forecast, by Therapeutic Area
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Therapeutic Area, 2020-2035
  - Depression and Anxiety Disorders
  - Schizophrenia and Psychotic Disorders
  - Bipolar Disorder
  - Substance Use Disorders
  - Others
- Market Attractiveness Analysis, by Therapeutic Area
Global Precision Psychiatry Market Analysis and Forecast, by End-user
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by End-user, 2020-2035
  - Hospitals & Clinics
  - Clinical Laboratories
  - Others
- Market Attractiveness Analysis, by End-user
Global Precision Psychiatry Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2020-2035
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness Analysis, by Region
North America Precision Psychiatry Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Service Type, 2020-2035
  - Genetic Testing
  - Biomarker Analysis
  - Data Analytics & Interpretation Services
  - Others
- Market Value Forecast, by Technology, 2020-2035
  - Next-Generation Sequencing (NGS)
  - Immunoassay
  - Mass Spectrometry
  - Others
- Market Value Forecast, by Therapeutic Area, 2020-2035
  - Depression and Anxiety Disorders
  - Schizophrenia and Psychotic Disorders
  - Bipolar Disorder
  - Substance Use Disorders
  - Others
- Market Value Forecast, by End-user, 2020-2035
  - Hospitals & Clinics
  - Clinical Laboratories
  - Others
- Market Value Forecast, by Country, 2020-2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Service Type
  - By Technology
  - By Therapeutic Area
  - By End-user
  - By Country
Europe Precision Psychiatry Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Service Type, 2020-2035
  - Genetic Testing
  - Biomarker Analysis
  - Data Analytics & Interpretation Services
  - Others
- Market Value Forecast, by Technology, 2020-2035
  - Next-Generation Sequencing (NGS)
  - Immunoassay
  - Mass Spectrometry
  - Others
- Market Value Forecast, by Therapeutic Area, 2020-2035
  - Depression and Anxiety Disorders
  - Schizophrenia and Psychotic Disorders
  - Bipolar Disorder
  - Substance Use Disorders
  - Others
- Market Value Forecast, by End-user, 2020-2035
  - Hospitals & Clinics
  - Clinical Laboratories
  - Others
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Service Type
  - By Technology
  - By Therapeutic Area
  - By End-user
  - By Country/Sub-region
Asia Pacific Precision Psychiatry Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Service Type, 2020-2035
  - Genetic Testing
  - Biomarker Analysis
  - Data Analytics & Interpretation Services
  - Others
- Market Value Forecast, by Technology, 2020-2035
  - Next-Generation Sequencing (NGS)
  - Immunoassay
  - Mass Spectrometry
  - Others
- Market Value Forecast, by Therapeutic Area, 2020-2035
  - Depression and Anxiety Disorders
  - Schizophrenia and Psychotic Disorders
  - Bipolar Disorder
  - Substance Use Disorders
  - Others
- Market Value Forecast, by End-user, 2020-2035
  - Hospitals & Clinics
  - Clinical Laboratories
  - Others
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - China
  - India
  - Japan
  - South Korea
  - Australia
  - ASEAN
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Service Type
  - By Technology
  - By Therapeutic Area
  - By End-user
  - By Country/Sub-region
Latin America Precision Psychiatry Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Service Type, 2020-2035
  - Genetic Testing
  - Biomarker Analysis
  - Data Analytics & Interpretation Services
  - Others
- Market Value Forecast, by Technology, 2020-2035
  - Next-Generation Sequencing (NGS)
  - Immunoassay
  - Mass Spectrometry
  - Others
- Market Value Forecast, by Therapeutic Area, 2020-2035
  - Depression and Anxiety Disorders
  - Schizophrenia and Psychotic Disorders
  - Bipolar Disorder
  - Substance Use Disorders
  - Others
- Market Value Forecast, by End-user, 2020-2035
  - Hospitals & Clinics
  - Clinical Laboratories
  - Others
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Service Type
  - By Technology
  - By Therapeutic Area
  - By End-user
  - By Country/Sub-region
Middle East & Africa Precision Psychiatry Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Service Type, 2020-2035
  - Genetic Testing
  - Biomarker Analysis
  - Data Analytics & Interpretation Services
  - Others
- Market Value Forecast, by Technology, 2020-2035
  - Next-Generation Sequencing (NGS)
  - Immunoassay
  - Mass Spectrometry
  - Others
- Market Value Forecast, by Therapeutic Area, 2020-2035
  - Depression and Anxiety Disorders
  - Schizophrenia and Psychotic Disorders
  - Bipolar Disorder
  - Substance Use Disorders
  - Others
- Market Value Forecast, by End-user, 2020-2035
  - Hospitals & Clinics
  - Clinical Laboratories
  - Others
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Service Type
  - By Technology
  - By Therapeutic Area
  - By End-user
  - By Country/Sub-region
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - Labcorp
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Myriad Genetics, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - TruGenomix, Inc
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - GeneDx , LLC
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Genomind
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - CNSDose
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - MedGenome
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - GeneHealth Global Research & Diagnostics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Quest Diagnostics Incorporated
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Illumina, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - F. Hoffmann-La Roche Ltd
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Bio-Rad Laboratories, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - QIAGEN
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Thermo Fisher Scientific Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Fulgent Genetics
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments

List of Table

Table 01: Global Precision Psychiatry Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
Table 02: Global Precision Psychiatry Market Value (US$ Bn) Forecast, By Technology, 2020 to 2035
Table 03: Global Precision Psychiatry Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
Table 04: Global Precision Psychiatry Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 05: Global Precision Psychiatry Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 06: North America Precision Psychiatry Market Value (US$ Bn) Forecast, by Country, 2020-2035
Table 07: North America Precision Psychiatry Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
Table 08: North America Precision Psychiatry Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 09: North America Precision Psychiatry Market Value (US$ Bn) Forecast, by Therapeutic Area, 2020 to 2035
Table 10: North America Precision Psychiatry Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 11: Europe Precision Psychiatry Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 12: Europe Precision Psychiatry Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
Table 13: Europe Precision Psychiatry Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 14: Europe Precision Psychiatry Market Value (US$ Bn) Forecast, by Therapeutic Area, 2020 to 2035
Table 15: Europe Precision Psychiatry Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 16: Asia Pacific Precision Psychiatry Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 17: Asia Pacific Precision Psychiatry Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
Table 18: Asia Pacific Precision Psychiatry Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 19: Asia Pacific Precision Psychiatry Market Value (US$ Bn) Forecast, by Therapeutic Area, 2020 to 2035
Table 20: Asia Pacific Precision Psychiatry Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 21: Latin America Precision Psychiatry Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 22: Latin America Precision Psychiatry Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
Table 23: Latin America Precision Psychiatry Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 24: Latin America Precision Psychiatry Market Value (US$ Bn) Forecast, by Therapeutic Area, 2020 to 2035
Table 25: Latin America Precision Psychiatry Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035
Table 26: Middle East and Africa Precision Psychiatry Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
Table 27: Middle East and Africa Precision Psychiatry Market Value (US$ Bn) Forecast, by Service Type, 2020 to 2035
Table 28: Middle East and Africa Precision Psychiatry Market Value (US$ Bn) Forecast, by Technology, 2020 to 2035
Table 29: Middle East and Africa Precision Psychiatry Market Value (US$ Bn) Forecast, by Therapeutic Area, 2020 to 2035
Table 30: Middle East and Africa Precision Psychiatry Market Value (US$ Bn) Forecast, by End-user, 2020 to 2035

List of Figure

Figure 01: Global Precision Psychiatry Market Value Share Analysis, by Service Type, 2024 and 2035
Figure 02: Global Precision Psychiatry Market Attractiveness Analysis, by Service Type, 2025 to 2035
Figure 03: Global Precision Psychiatry Market Revenue (US$ Bn), by Genetic Testing, 2020 to 2035
Figure 04: Global Precision Psychiatry Market Revenue (US$ Bn), by Biomarker Analysis, 2020 to 2035
Figure 05: Global Precision Psychiatry Market Revenue (US$ Bn), by Data Analytics & Interpretation Services, 2020 to 2035
Figure 06: Global Precision Psychiatry Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 07: Global Precision Psychiatry Market Value Share Analysis, by Technology, 2024 and 2035
Figure 08: Global Precision Psychiatry Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 09: Global Precision Psychiatry Market Revenue (US$ Bn), by Next-Generation Sequencing (NGS), 2020 to 2035
Figure 10: Global Precision Psychiatry Market Revenue (US$ Bn), by Immunoassay, 2020 to 2035
Figure 11: Global Precision Psychiatry Market Revenue (US$ Bn), by Mass Spectrometry, 2020 to 2035
Figure 12: Global Precision Psychiatry Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 13: Global Precision Psychiatry Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
Figure 14: Global Precision Psychiatry Market Attractiveness Analysis, by Therapeutic Area, 2025 to 2035
Figure 15: Global Precision Psychiatry Market Revenue (US$ Bn), by Depression and Anxiety Disorders, 2020 to 2035
Figure 16: Global Precision Psychiatry Market Revenue (US$ Bn), by Schizophrenia and Psychotic Disorders, 2020 to 2035
Figure 17: Global Precision Psychiatry Market Revenue (US$ Bn), by Bipolar Disorder, 2020 to 2035
Figure 18: Global Precision Psychiatry Market Revenue (US$ Bn), by Substance Use Disorders, 2020 to 2035
Figure 19: Global Precision Psychiatry Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 20: Global Precision Psychiatry Market Value Share Analysis, by End-user, 2024 and 2035
Figure 21: Global Precision Psychiatry Market Attractiveness Analysis, by End-user, 2024 and 2035
Figure 22: Global Precision Psychiatry Market Revenue (US$ Bn), by Hospitals & Clinics, 2025 to 2035
Figure 23: Global Precision Psychiatry Market Revenue (US$ Bn), by Clinical Laboratories, 2020 to 2035
Figure 24: Global Precision Psychiatry Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 25: Global Precision Psychiatry Market Value Share Analysis, By Region, 2024 and 2035
Figure 26: Global Precision Psychiatry Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 27: North America Precision Psychiatry Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 28: North America Precision Psychiatry Market Value Share Analysis, by Country, 2024 and 2035
Figure 29: North America Precision Psychiatry Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 30: North America Precision Psychiatry Market Value Share Analysis, by Service Type, 2024 and 2035
Figure 31: North America Precision Psychiatry Market Attractiveness Analysis, by Service Type, 2025 to 2035
Figure 32: North America Precision Psychiatry Value Share Analysis, by Technology, 2025 to 2035
Figure 33: North America Precision Psychiatry Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 34: North America Precision Psychiatry Market Value Share Analysis, by Therapeutic Area, 2025 to 2035
Figure 35: North America Precision Psychiatry Market Attractiveness Analysis, by Therapeutic Area, 2025 to 2035
Figure 36: North America Precision Psychiatry Market Value Share Analysis, by End-user, 2024 and 2035
Figure 37: North America Precision Psychiatry Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 38: Europe Precision Psychiatry Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 39: Europe Precision Psychiatry Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 40: Europe Precision Psychiatry Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 41: Europe Precision Psychiatry Market Value Share Analysis, by Service Type, 2024 and 2035
Figure 42: Europe Precision Psychiatry Market Attractiveness Analysis, by Service Type, 2025 to 2035
Figure 43: Europe Precision Psychiatry Market Value Share Analysis, by Technology, 2024 and 2035
Figure 44: Europe Precision Psychiatry Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 45: Europe Precision Psychiatry Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 46: Europe Precision Psychiatry Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
Figure 47: Europe Precision Psychiatry Market Value Share Analysis, by End-user, 2024 and 2035
Figure 48: Europe Precision Psychiatry Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 49: Asia Pacific Precision Psychiatry Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 50: Asia Pacific Precision Psychiatry Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 51: Asia Pacific Precision Psychiatry Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 52: Asia Pacific Precision Psychiatry Market Value Share Analysis, by Service Type, 2024 and 2035
Figure 53: Asia Pacific Precision Psychiatry Market Attractiveness Analysis, by Service Type, 2025 to 2035
Figure 54: Asia Pacific Precision Psychiatry Market Value Share Analysis, by Technology, 2024 and 2035
Figure 55: Asia Pacific Precision Psychiatry Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 56: Asia Pacific Precision Psychiatry Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 57: Asia Pacific Precision Psychiatry Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
Figure 58: Asia Pacific Precision Psychiatry Market Value Share Analysis, by End-user, 2024 and 2035
Figure 59: Asia Pacific Precision Psychiatry Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 60: Latin America Precision Psychiatry Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 61: Latin America Precision Psychiatry Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 62: Latin America Precision Psychiatry Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 63: Latin America Precision Psychiatry Market Value Share Analysis, by Service Type, 2024 and 2035
Figure 64: Latin America Precision Psychiatry Market Attractiveness Analysis, by Service Type, 2025 to 2035
Figure 65: Latin America Precision Psychiatry Market Value Share Analysis, by Technology, 2024 and 2035
Figure 66: Latin America Precision Psychiatry Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 67: Latin America Precision Psychiatry Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
Figure 68: Latin America Precision Psychiatry Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
Figure 69: Latin America Precision Psychiatry Market Value Share Analysis, by End-user, 2024 and 2035
Figure 70: Latin America Precision Psychiatry Market Attractiveness Analysis, by End-user, 2025 to 2035
Figure 71: Middle East and Africa Precision Psychiatry Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 72: Middle East and Africa Precision Psychiatry Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 73: Middle East and Africa Precision Psychiatry Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 74: Middle East and Africa Precision Psychiatry Market Value Share Analysis, by Service Type, 2024 and 2035
Figure 75: Middle East and Africa Precision Psychiatry Market Attractiveness Analysis, by Service Type, 2025 to 2035
Figure 76: Middle East and Africa Precision Psychiatry Market Value Share Analysis, by Technology, 2024 and 2035
Figure 77: Middle East and Africa Precision Psychiatry Market Attractiveness Analysis, by Technology, 2025 to 2035
Figure 78: Middle East and Africa Precision Psychiatry Market Value Share Analysis, by Therapeutic Area, 2024 and 2035
Figure 79: Middle East and Africa Precision Psychiatry Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
Figure 80: Middle East and Africa Precision Psychiatry Market Value Share Analysis, by End-user, 2024 and 2035
Figure 81: Middle East and Africa Precision Psychiatry Market Attractiveness Analysis, by End-user, 2025 to 2035